Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)
Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)
Active, not recruiting · NCT06563323 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG) | Skin Ulcer, Skin and Connective Tissue Diseases, pyoderma, pyoderma gangrenosum, skin disorder, skin vascular disease | Active, not recruiting | Phase 2 | 2026-09-28 | NCT06563323 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Janssen Scientific Affairs, LLC | 37 |
| Ohio State University | 297 |
| Oregon Health and Science University | 244 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ohio State Dermatology | Columbus | United States | 1 |
| Oregon Health and Science University | Portland | United States | 382 |